Introduction
In recent years, it has become increasingly clear that post-transcriptional control is an important mechanism for regulating gene expression. This is more prominent in the regulation of genes involved in critical processes of cellular physiology such as proto-oncogenes, growth factors, genes involved in in¯ammatory response etc. Regulation of these genes at the level of mRNA stability has been established (reviewed in: Ross, 1995) and furthermore a number of examples indicate regulation at the level of translation, as well (Kruys et al., 1988; Bernstein et al., 1997; Black et al., 1997; Yang et al., 1997) . The elements governing either of these mechanisms are usually present in the untranslated regions of the mRNA. In the 3'UTR besides speci®c cis elements, another general regulatory element exists, the poly(A) tail. It is present at the 3' end of virtually all mRNAs and aects cytoplasmic mRNA stability and translatability (Sachs and Wahle, 1993) .
Withstanding mRNAs degraded through regulated endonucleolytic cleavage, it is believed that both stable and unstable mRNAs do not begin to decay until the poly(A) tail is reduced to a minimum length (Jacobson and Peltz, 1996) . These observations support the notion that as long as a long poly(A) tail is present the mRNA is protected from rapid indiscriminate degradation. Dierences in the stability of mRNAs re¯ect dierences in the rate of deadenylation and/or the rate of degradation of the oligoadenylated form of the message (Decker and Parker, 1994; Chen and Shyu, 1995) .
On the other hand, there is extensive evidence that the adenylation status might play a role in the translatability of mRNAs (Jackson and Standart, 1990; Sachs, 1990; Gallie, 1991) . Findings demonstrating that the poly(A) binding protein-poly(A) tail complex facilitates the recruitment of the 40S ribosomal subunit (Tarun and Sachs, 1995) combined with other evidence (Munroe and Jacobson, 1990; Christensen et al., 1987) suggest that the poly(A) tail and the cap structure may physically interact to facilitate initiation of translation. This hypothesis may account for the fact that most of the evidence assigns a positive role for the poly(A) tail in translatability, the most overwhelming examples being those from developmental systems (Bachvarova, 1992) . In these systems regulated cytoplasmic polyadenylation of maternal mRNAs provides a control mechanism for the translational activation of stored mRNAs at various times during oocyte maturation and early development, when little or no mRNA is synthesized (Sheets et al., 1994 (Sheets et al., , 1995 Salles et al., 1994) .
On the other hand, there are cases where translational activation correlates with deadenylation. Even though during Xenopus maturation and early embryogenesis where adenylation correlating with translational activation is the general rule, histone mRNAs deadenylation coincides with their translational activation. At least, in the case of histone H4 mRNA the deadenylation dependent maturation involves complete removal of the poly(A) tail (Ballantine and Woodland, 1985) . Similar results have been obtained in mammalian spermiogenesis in which shortening of the poly(A) tail of the protamine mRNA occurs at the same time as translation of this mRNA commences (Kleene, 1989) . Gra® et al. (1993) have shown that beta-1 interferon mRNA with long poly(A) tails is not eciently translated in vitro, in contrast to its oligoadenylated counterpart. This eect is attributed to elements in the 3'UTR which cooperating with the poly(A) tail, inhibit translation. Furthermore, IFN-b transcripts with elongated poly(A) tails formed in vivo, are associated with reduced translation of this message (Dehlin et al., 1996) .
We have previously shown that the rapid deadenylation of c-myc mRNA leads to the formation of a relatively more stable oligoadenylated c-myc mRNA (Ioannidis et al., 1996) . The question arises whether this population represents an inactive degradation intermediate in the process of c-myc mRNA decay or whether it serves a functional role. One way to elucidate in vivo the function of oligoadenylated c-myc mRNA was to use the polyadenylation inhibitor cordycepin which is known to prevent the formation of mRNA with long poly(A) tails but allows for the correct splicing and transport of transcribed mRNA (Zeevi et al., 1982) . Addition of cordycepin had as a result the dissociation of c-MYC protein from c-myc mRNA levels. The discrepancy observed between c-myc mRNA steady state levels and protein accumulation in cordycepin treated cells in comparison to the control cells indicates that this mRNA is subjected to translational regulation. Furthermore, it appears that the short poly(A) tailed c-myc mRNA is very eciently translated.
Results
Enhanced presence of oligoadenylated c-myc mRNA species in vivo We have performed RNase H mapping of the 3' end of c-myc mRNA which revealed that all the various poly(A) tail sizes were not evenly represented ( Figure  1 ). The species of c-myc mRNA whose presence was more pronounced were those which possessed short poly(A) tails, as indicated by the arrow. This population was enhanced when overexpression of c-myc mRNA was achieved in HeLa 1C5 cells upon dexamethasone induced transcription of the c-myc gene under the control of the MMTV-LTR. However, the existence of a prominent amount of short tailed c-myc mRNA was also demonstrated in the parental cell line HeLa (data not shown) and in the human diploid FS-4 ®broblastic cell line (Figure 1 , lane 4) which expresses normally regulated c-myc (Lin and Vilcek, 1987) . It has been reported that the 3'UTR derived from unstable mRNAs direct rapid deadenylation of chimaeric mRNAs leading to the formation of oligoadenylated species which decay further with ®rst order kinetics. Among those studied the c-myc 3'UTR confers the fastest rate of deadenylation upon the chimaeric mRNAs (Chen and Shyu, 1994) .
The enhanced representation of oligoadenylated c-myc mRNA species can be attributed to the fact that the decay of normal c-myc mRNA has been shown to be a two step process (Swartwout and Kinniburgh, 1989) of which the later appears to be rate limiting (Chen and Shyu, 1994; Ioannidis et al., 1996) . The question arising from the above observations is whether the oligoanenylated c-myc mRNA can be translated or it represents an inactive decay intermediate.
Eects of cordycepin addition upon c-myc mRNA
One way to elucidate the in vivo function of oligoadenylated c-myc mRNA was to use the polyadenylation inhibitor cordycepin which is known to prevent the formation of mRNA with long poly(A) tails but allows for the correct splicing and transport of transcribed mRNA (Zeevi et al., 1982) . Addition of the polyadenylation inhibitor to the HeLa 1C5 cells, resulted in a decrease of the steady state c-myc mRNA levels but it did not aect the levels of the stable GAPDH mRNA, within 3 h. The reduction of c-myc mRNA levels was correlated to the amount of inhibitor used (Figure 2A) . At a concentration of 20 mg/ml a 4 ± 5-fold reduction in c-myc mRNA levels could be measured.
In order to ascertain the expected alterations in the structure and to follow the fate of c-myc mRNA formed in the presence of the polyadenylation inhibitor, RNase H mapping of the 3' end of c-myc mRNA, isolated from cordycepin treated and control cells at various time points after actinomycin D addition, was performed. As shown in Figure 2 (B,C) the c-myc mRNA is converted within 15 min to its deadenylated form. Addition of cordycepin to the cells resulted, as expected, in the loss of the c-myc mRNA species with long poly(A) tails. Nevertheless, the oligoadenylated c-myc mRNA synthesized in the Figure 1 Detection of a distinct population of c-myc mRNA with short poly(A) tails. RNAse H mapping was performed on cmyc mRNA isolated from HeLa 1C5 cells using oligo 2 (lane 1), oligo 1 (lane 2) and no oligo (control reaction, lane 3) after induction with dexamethasone (10 75 M for 1 h) and from resting FS-4 cells after induction with 10% FCS for 1 h, using oligo 2 (lane 4). The brackets indicate the distribution of the poly(A) tail carrying fragments derived from the major polyadenylation site pA 2 which extend over 471 nt when using oligo 1 (lane 2) and 411 nt when using oligo 2 (lanes 1 and 4). A distinct accumulation of fragments was observed towards the smaller sizes as pointed by the arrows. The positions of RNA molecular size markers are indicated on the left presence of cordycepin decays at similar rates as its naturally formed counterpart, despite the modi®cation at its 3' end ( Figure 2 ).
Translational eciency of oligoadenylated c-myc mRNA
Addition of cordycepin did not aect c-myc mRNA half life and thus, in the presence of the inhibitor, all the available c-myc mRNA is oligo or de-adenylated within a short time. Due to the fact that in mammals the average half-life of stable mRNAs ± which comprise more than 90% of total mRNAs ± is over 12 h, 3 h after cordycepin addition, the levels of the majority of stable mRNAs synthesized before the addition of the inhibitor were not grossly aected, as exempli®ed by the levels of GAPDH mRNA. Thus, cordycepin addition resulted within 3 h in the reduction of c-myc mRNA steady state levels with the remaining population consisting of the oligoadenylated form of the message. Given the fact that c-MYC proteins are very unstable ± 30 min half life (Hann and Eiseman, 1984) ± the protein detected 3 h after cordycepin addition would be the translation product of the mRNA synthesized in the presence of the inhibitor. If the length of the poly(A) tail was inconsequential to the rate of translation of c-myc mRNA one would expect that the levels of c-MYC protein would re¯ect the reduced steady state levels of the corresponding mRNA observed upon addition of cordycepin. If the shortening of the poly(A) tail had an adverse eect upon the translatability of this message then the levels of c-MYC protein should be further diminished. To address this question Western blot analysis was performed after addition of cordycepin. The data in Figure 3 (A and B) demonstrated that addition of cordycepin up to 60 mg/ml, despite the decrease in the steady state c-myc mRNA levels, had no measurable eect upon c-MYC protein levels. These ®ndings were con®rmed with four dierent monoclonal antibodies and one polyclonal antibody recognizing dierent epitopes of the protein. The sole or the most prominent band recognized by all of the above antibodies corresponded to a protein of approximately 64 kD molecular weight. The recognition of this protein was abolished when the incubation was performed in the presence of the immunizing peptide (C-19). Incubation in the presence of GST-c-MYC fusion protein abolished (C-33) or diminished (C-8) binding ( Figure 3B ). Thus, using all the speci®c antibodies no changes in the c-MYC protein levels could be measured with increasing concentrations of cordycepin, despite the gradual reduction in c-myc mRNA levels. At a concentration of 20 mg/ml a 4 ± 5-fold decrease in c-myc mRNA levels could be measured (Figure 2A ). At 40 mg/ml the reduction was estimated to be larger than sevenfold. However, this is a rough approximation since at this and higher cordycepin concentrations, no accurate measurements could be made ± overexposure of the autoradiograms was inevitable in order to detect the remaining low levels of c-myc mRNA, resulting in loss of linearity.
Similar results were obtained when cordycepin was added to other established cell lines. In addition, the expression of c-MYC proteins was determined after the exposure of cells to physiological agents known to decrease the c-myc mRNA steady state levels. It is documented that IFN-a decreases c-myc mRNA steady state levels up to 50% in Daudi cells (Dani et al., 1985) . IFN-a (1000 units/ml) was added for 24 h to Daudi cells and c-MYC protein levels in these cells were compared to those of control cells and cells exposed to cordycepin for 3 h. In ®gure 4 is shown that cordycepin caused a dose dependent decrease in c-myc mRNA levels which was not re¯ected in the protein levels. On the other hand, IFN-a which downregulates c-myc expression, without aecting the distribution of poly(A) tail size of c-myc mRNA, produced a concomitant decrease in protein levels. Similar results ( Figure 5 ) were also obtained with the cell line HL-60 using the dierentiation agent retinoic acid which results in the reduction the c-myc mRNA levels due to transcriptional inhibition (Krumm et al., 1992) .
These ®ndings indicate that the reduction of c-myc mRNA steady state levels is re¯ected upon protein levels when this is caused by physiological agents. On the other hand, cordycepin resulted in the reduction of c-myc mRNA levels and the enrichment of the remaining message with short tailed species but did To test this possibility, we followed the protein decay process after addition of cycloheximide in control and cordycepin treated cells. The data in Figure 6 did not reveal any stabilizing eect of cordycepin upon c-MYC proteins since they decayed at comparable rates in both control and cordycepin treated cells.
The above indicate that cordycepin addition resulted in the dissociation between c-myc mRNA and protein levels.
Eect of cordycepin addition upon c-fos expression
In order to ascertain whether the eect of the adenylation inhibitor upon c-myc expression was generalized and aected other genes in a similar manner, we studied the expression of c-fos in the presence of cordycepin. c-fos is a tightly regulated (at the level of transcription) early response gene, coding for short lived mRNA (Greenberg and Zi, 1984) and protein products (Kovary and Bravo, 1991) and its expression is induced by many growth factors present in serum. HeLa 1C5 cells proliferate even at low serum concentrations. However, it has been shown that unlike c-myc whose levels are independent of cell cycle stage Hann et al., 1985) , c-fos mRNA in cycling cells is barely detectable but its induction is as sensitive to growth factors as in quiescent cells (Bravo et al., 1986) . Thus, high levels of c-fos expression were achieved in HeLa 1C5 cells by FCS addition to cells maintained at low serum concentration for 48 h. As shown in Figure 7 lower levels of c-fos mRNA were induced in the presence of cordycepin resulting in lower protein levels as well. Under the same conditions c-MYC protein levels were not aected by cordycepin. This ®nding excludes the possibility that the eect of cordycepin upon c-myc is due to an indiscriminate eect upon the translational machinery.
The data presented show that cordycepin addition to cell cultures resulted in the dissociation of c-myc Exponentially growing HL-60 cells were exposed to 10 mM ®nal concentration retinoic acid (RA) for 24 h before RNA and protein isolation. Alternatively exponentially growing HL-60 cells were exposed to cordycepin (20 or 40 mg/ml ®nal concentration) and RNA was isolated 3 h later while protein was collected 4 h after cordycepin addition. Total cell lysates were prepared at a density of 6610 mRNA/protein levels. Since this could not be attributed to changes in the stability of the c-MYC protein, it is indicative of translational control. Based on the assumption that the ratio protein synthesized: template mRNA re¯ects the translational eciency of a given message, it appears that the oligoadenylated cmyc mRNA synthesized in the presence of cordycepin was more eciently translated than its counterpart with a heterogeneous size distribution of the poly(A) tail. A four-to ®vefold increase in the protein/mRNA ratio can be estimated when cells are treated with 20 mg/ml cordycepin. The ratio greatly increases at higher concentrations of the inhibitor even though the magnitude cannot be quantitated, due to very low levels of remaining c-myc mRNA. The possibility exists also that the determining factor for c-MYC levels is not mRNA availability but either inhibitory mechanisms controlling c-myc mRNA translation and/or other factors allowing a quota of c-myc mRNA molecules to be translated. However, the fact remains that elimination of a long poly(A) tail does not thwart the translation of this mRNA.
Discussion
Study of the distribution of the poly(A) tail length of c-myc mRNA has revealed a distinct prevailing population with short poly(A) tails, derived through sequential deadenylation. To elucidate whether this population serves a function or whether it represents an inactive degradation intermediate, the polyadenylation inhibitor cordycepin was used to further enrich the oligoadenylated fraction of c-myc mRNA and observe the eects upon c-MYC protein levels. It has been demonstrated that the poly(A) de®cient mRNA synthesized in the presence of cordycepin is correctly spliced, transferred to the cytoplasm and enters the polyribosomes (Zeevi et al., 1982) . Cordycepin addition resulted in a decline in c-myc mRNA levels while the remaining message was enriched in the oligoadenylated form, in all cell lines tested. The cell line HeLa 1C5 in which high levels of c-myc mRNA could be induced, was used in order to be able to follow the metabolic fate of the message. The c-myc mRNA synthesized in the presence of cordycepin despite its 3' end modi®cation was neither stabilized nor destabilized but had an apparent decay rate similar to that of its naturally formed counterpart derived through deadenylation (Figure 2) . The proportional to the amount of the inhibitor used decrease in c-myc mRNA steady state levels could be attributed to transcriptional inhibition (Beach and Ross, 1978) . Within 3 h, stable mRNAs representing the vast majority of the cellular messages are not grossly aected by the addition of cordycepin and the cell should not be depleted of translatable mRNA, as exempli®ed by the levels of Figure 6 Cordycepin addition did not aect the stability of c-MYC proteins. The stability of c-MYC proteins was compared in control and cells treated with cordycepin (60 mg/ml) for 3 h. Cycloheximide (10 mg/ml) was added and the levels of c-MYC protein were determined at the times indicated. The antibodies used are indicated at the left side of the blots GAPDH mRNA. Under these conditions the translatability of oligoadenylated c-myc mRNA is determined in a competitive milieu. c-MYC proteins remained highly unstable in the presence of cordycepin, thus the protein detected 3 h after cordycepin addition and thereafter re¯ected the translation product of the oligodenylated message.
We observed that in the presence of cordycepin c-MYC proteins do not follow the marked decrease in c-myc mRNA levels. This was not proven to be an indiscriminate eect of cordycepin since the reduction in c-fos mRNA was re¯ected upon c-FOS protein.
Discrepancies between mRNA levels and protein accumulation such as those observed with c-myc mRNA in the presence of cordycepin are considered as indicative of translational control.
The results presented above may be due to the fact that only a small prescribed number of c-myc mRNA molecules is translated at a given time. In that case the reduction of c-myc mRNA which became dramatic at high cordycepin concentrations, must not have fallen under the threshold of the mRNA molecules meant to be translated and thus, no changes in the protein levels could be detected. The above hypothesis seems to be contradicted by the data indicating that the reduction in c-myc mRNA steady state levels caused by physiological agents is re¯ected upon protein levels. However, the changes in the physiology of the cell induced by those agents should be taken into consideration. From that view point the eect of IFN-a upon Daudi cells and retinoic acid upon HL-60 cells, i.e. growth arrest and dierentiation respectively, may dictate the concomitant decrease in c-myc mRNA and c-MYC protein levels. If c-myc mRNA is subjected to translational control, changes in the physiological conditions may modulate this mechanism either augmenting it or relaxing it. Translational enhancement during the recovery phase of c-myc mRNA and protein levels after induction of dierentiation in MEL cells, has been suggested before (Spotts and Hann, 1990) . Additional examples have been demonstrated for other mRNAs whose expression is translationally regulated (Bernstein et al., 1995; Han et al., 1990) .
Proto-oncogenes may be genuine candidates for translational repression. For many proto-oncogenes' mRNAs, the presence of a long 5'UTR burdened with AUG initiation codons or high GC content led to the prediction that they must be ineciently translated (Kozak, 1991) . There are observations as well as experimental evidence indicating that removal of portions of these sequences dramatically improves the expression of these mRNAs (Rao et al., 1988; Marth et al., 1988) . Evidence of increased mobilization of c-myc mRNA to polysomes due to a mutation in the 5'UTR in multiple myeloma cell lines suggests that this mRNA is not eciently translated (Paulin et al., 1996) . c-myc 5'UTR, which is highly conserved among dierent species, has been proposed to exert negative translational control due to the formation of highly stable secondary structure which inhibits the scanning mechanism of translation as suggested by in vitro experiments (Darveau et al., 1985) . This inhibitory eect can be circumvented by the presence of an internal ribosome entry segment (IRES) identi®ed in the 5' c-myc UTR which allows for cap independent translation (Nanbru et al., 1997; Stoneley et al., 1998).
Translational repression or regulated translatability may be exerted through the 3'UTR, as well (Yang et al., 1997) . This has been demonstrated using chimaeric mRNAs carrying the 3'UTR of c-fos, GM-CSF, bInterferon (Kruys et al., 1988 (Kruys et al., , 1989 or hu-TNF (Han et al., 1990) . Translational repression can be relaxed due to alterations in cellular physiology, as has been demonstrated for MEF2A (Black et al., 1997) and lipoprotein lipase mRNA (Ranganathan et al., 1997) . In the latter case a regulatory trans factor recognizing the 3'UTR has been identi®ed.
Translational regulation of c-myc mRNA expression, could be operative if a predetermined number of molecules is`tagged' to be translated or through feedback inhibition. Tagging for translation by a cellular factor present in limited amounts has been implied for ornithine decarboxylase mRNA (Lorenzini and Scheer, 1997) . Our original goal when using cordycepin was to prevent the formation of long poly(A) tails, to enrich the short tailed c-myc mRNA population and investigate its function. This approach would allow us to determine the translatability of this predominant c-myc mRNA species in vivo and in a competitive milieu. A variety of dierent experimental approaches have indicated that in addition to being a modulator of mRNA turnover, the poly(A) status of mRNA can be a determinant of mRNA translational eciency. It has been postulated that this is achieved by the interaction of the poly(A) binding protein PAB1 with the cap binding protein via the eIF-4G which stimulates the recruitment of the 40 S ribosomal subunit (Sachs et al., 1997) . The eIF-4 holoenzyme is instrumental in cap dependent initiation of translation and its concentration is limiting. Furthermore, the concentration requirement is considered to be positively correlated to the putative degree of secondary structure at the 5' end of the mRNA (Koromilas et al., 1992) . On the other hand it is believed that mRNAs translated in a cap independent manner require very little if any eIF-4 (reviewed in: Jackson et al., 1995) .
Even though the overwhelming majority of examples attribute a positive role for the poly(A) tail in translatability there has been evidence that for certain mRNAs the oligoadenylated species represents the translationally active form. Poly(A)+ vasopressin mRNA upon injection to diabetic rats was 10-fold less eective in eliciting physiological response and measurable protein levels in plasma, compared with poly(A)-mRNA. Poly(A) tail removal restored functional activity (Maciejewski-Lenoir et al., 1993) . In vitro studies suggest that a long poly(A) tail prevents translation of human Beta-1 Interferon mRNA. However, translational eciency was considerably improved when the poly(A) tract was shortened to 11 A residues. This ®nding was attributed to the presence of the element UUAUUUAU in the 3'UTR of this message which co-operates with a long poly(A) tail to inhibit translation (Gra® et al., 1993) . This element is responsible for the inhibitory role upon translation which has been also demonstrated for c-fos, GM-CSF and TNF 3'UTRs. This octanucleotide, or the core sequence AUUUA, is a common feature in the 3'UTR of unstable mRNAs and was initially identi®ed as an instability element directing rapid deadenylation (Shaw and Kamen, 1986; Zubiaga et al., 1995) . The c-myc mRNA contains two such elements which may link deadenylation to translation, inhibiting the latter until the message is deadenylated. It has been demonstrated that IFN-b mRNA with elongated poly(A) tails, formed in vivo, in virus infected cells, is not eciently translated (Dehlin et al., 1996) . The strategy utilized by the virus to downregulate the defence speci®c protein supports the in vitro data that this message is translated in its oligoadenylated form.
The eect of the polyadenylation inhibitor on the length of the poly(A) tail may account for the increased translatability of c-myc mRNA. One posibility is that the lack of poly(A) tails in the newly synthesized c-myc mRNA thwarts the poly(A) assisted cap dependent translation ± which would be inecient for c-myc mRNA due to its highly structured 5'UTR ± and promotes the utilization of the highly ecient IRES. Another posibility is that a long poly(A) tail inhibits translation. It has been reported that a poly(A) tail longer than 80 nt is bound simultaneously with the 3'UTR of c-myc mRNA by Elav like proteins in vitro (Ma et al., 1997) Such an interaction may impair the stimulatory eect of the poly(A) tail upon cap depended translation. Shortening of the poly(A) tail would release the binding and allow it to resume its function. This may imply that the more stable than its precursor, naturally formed oligoadenylated c-myc mRNA represents the translationally active form of this message as is indicated for certain mRNAs. In that case the rapid c-myc mRNA deadenylation leading to relatively more stable oligoadenylated intermediates may represent a prerequisite for the translational maturation of this message. At the same time the message is irrevocably on its way to its ®nal degradation. It has been documented that regulation of expression of the c-myc gene is eected by modulating the half-life of its mRNA. Considering the above, any modulation of the rate of deadenylation, even though it may determine the onset of the decay of the molecule, is not expected to aect the functional half-life of this message. Therefore, modi®cation of the functional half-life of c-myc mRNA would either involve alterations in the decay rate of the oligoadenylated form or an alternative mechanism would be required for the deactivation of this mRNA. There is evidence for an endonucleolytic decay of this message without prior deadenylation (Swartwout and Kinninburgh, 1989; Ioannidis et al., 1996) .
Materials and methods

Cell cultures
HeLa 1C5 cells were derived from a stable clone isolated from HeLa cells transfected with the eukaryotic expression vector pMSG-myc. Cell culture conditions and induction with dexamethasone were performed as previously described (Ioannidis et al., 1996) .
The human diploid ®broblastic cell line FS-4 was cultured for 48 h in DMEM plus 10% FCS and subsequently in DMEM with 0.25% FCS for 48 h before the induction with fresh medium containing 10% FCS. Cordycepin (Sigma Co), IFN-a2b (INTRON-A, Schering-Plough) or retinoic acid (Sigma Co) were added to actively dividing Daudi and HL-60 cells, respectively.
Northern hybridization
Total RNA was isolated as described by Chomczynski and Sacchi (1987) . Thirty mg of denatured total RNA were electrophoresed in 1.2% formaldehyde-agarose gels, transferred to nylon membranes (Zetaprobe, BioRad), immobilized and hybridized according to the manufacturer's instructions. Filters were hybridized with the speci®c c-myc (Pr3), c-fos (ON 118) and GAPDH end labelled deoxyoligonucleotides from Oncogene Science.
Mapping of the c-myc mRNA 3'UTR Oligonucleotide/RNase H treatment: c-myc mRNA was annealed to a speci®c DNA oligonucleotide and treated with RNase H(Gibco ± BRL). The speci®c antisense oligonucleotides used were CCTTACGCACAAAGAGT-TCCG (oligo 1) and CAAGTTCATAGGTGATTGCTC (oligo 2) as described in Ioannidis et al. (1996) . RNase H mapping was performed according to Brewer and Ross (1990) i.e. 40 mg of total RNA were ethanol precipitated, resuspended in 20 ml of 1 mM EDTA pH 7.4 and heated at 708C for 10 min. Oligonucleotide (0.5 mg) was added, and the mixture was incubated at 208C for 15 min. One ml of 4 M KCl was added and the mixture was incubated at 208C for 15 min, followed by the addition of 20 ml of TM buer (40 mM Tris HCl, pH 7.5, 60 mM MgCl 2 ). RNase H was added (®nal concentration 20 units/ml) and the digestion was performed at 378C. Following digestion RNA was ethanol precipitated. RNA samples were separated by length using a denaturing 4% polyacrylamide-urea gel as described by Stoeckle and Guan (1993) and transferred electophoretically to a charged membrane. The probe used was the end labelled deoxynucleotide GGCTAAATCTTT-CAGTCTCAAGACTCAGCCAAGGTTGTGAGGTTG.
Western blot analysis
Cells were lysed in RIPA buer (1% NP-40, 0.5% Na deoxycholate, 0.1% SDS in PBS) containing the following protease inhibitors: PMSF, 0.1 mg/ml, aprotinin, 50 mg/ml, sodium orthovanadate, 1 mM. Protein concentrations were determined according to Lowry et al (1950) .
Cell lysates were electrophoresed on SDS-PAGE gels and transferred electrophoretically to Immobilon-P (Millipore) membranes. The antibodies used in this study were for the c-MYC proteins: pan-myc, 0.5 mg/ml (OM-11-904, Cambridge Res. Biochem.), 9E10, 1 mg/ml (OM-11-908, Cambridge Res. Biochem.), C-33, 0.1 mg/ml (SC-42, Santa Cruz Biotech. Inc.), C-8 0.05 mg/ml (SC-41, Santa Cruz Biotech. Inc.) and C-19 0.1 mg/ml (SC-788, Santa Cruz Biotech. Inc.), for c-FOS: cfos (4), 0.1 mg/ml (SC-52, Santa Cruz Biotech. Inc.) and for the bcl-2 protein: Ab-1, 0.2 mg/ml (OP60, Oncogene Sc.). Blocking of the primary antibody C-19 was performed overnight at 48C using 10-fold by weight excess of the immunizing peptide (SC-788P Santa Cruz Biotech. Inc.) for C-19; for C-8 and C-33 a 10-fold by weight excess of the E. coli produced GST-MYC fusion protein containing aa 1 ± 262 of c-MYC (SC-4084, Santa Cruz Biotech. Inc.). Western blots were visualized with the ECL system by Amersham according to the instructions of the manufacturer. The bcl-2 protein (MW 26 kD) proven stable, was used as an internal standard in HeLa 1C5 cells. The ®lms were scanned using the UMAX Scanner (Vista-S6) and were quantitated using the Image 1.44 program.
